Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292, 344–347 (1975).

Article  CAS  PubMed  Google Scholar 

Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 292, 403–407 (1975).

Article  CAS  PubMed  Google Scholar 

Dalakas, M. C. Polymyositis, dermatomyositis, and inclusion-body myositis. N. Engl. J. Med. 325, 1487–1498 (1991).

Article  CAS  PubMed  Google Scholar 

Hoogendijk, J. E. et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul. Disord. 14, 337–345 (2004).

Article  PubMed  Google Scholar 

Love, L. A. et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70, 360–374 (1991).

Article  CAS  PubMed  Google Scholar 

Betteridge, Z. et al. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J. Autoimmun. 101, 48–55 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tansley, S. L. et al. Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort. J. Autoimmun. 84, 55–64 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

McHugh, N. J. & Tansley, S. L. Autoantibodies in myositis. Nat. Rev. Rheumatol. 14, 290–302 (2018).

Article  CAS  PubMed  Google Scholar 

Betteridge, Z. & McHugh, N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J. Intern. Med. 280, 8–23 (2016).

Article  CAS  PubMed  Google Scholar 

Papadopoulou, C., Chew, C., Wilkinson, M. G. L., McCann, L. & Wedderburn, L. R. Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care. Nat. Rev. Rheumatol. 19, 343–362 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Muro, Y., Ishikawa, A., Sugiura, K. & Akiyama, M. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-mi-2 autoantibodies. Rheumatology 51, 1508–1513 (2012).

Article  CAS  PubMed  Google Scholar 

Huang, H. L. et al. Coexistence of multiple myositis-specific antibodies in patients with idiopathic inflammatory myopathies. J. Clin. Med. 11, 6972 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta, L., Naveen, R., Gaur, P., Agarwal, V. & Aggarwal, R. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis. Semin. Arthritis Rheum. 51, 113–120 (2021).

Article  CAS  PubMed  Google Scholar 

Lundberg, I. E., Miller, F. W., Tjärnlund, A. & Bottai, M. Diagnosis and classification of idiopathic inflammatory myopathies. J. Intern. Med. 280, 39–51 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reichlin, M. & Mattioli, M. Description of a serological reaction characteristic of polymyositis. Clin. Immunol. Immunopathol. 5, 12–20 (1976).

Article  CAS  PubMed  Google Scholar 

Sato, S. et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 60, 2193–2200 (2009).

Article  CAS  PubMed  Google Scholar 

Sato, S. et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 52, 1571–1576 (2005).

Article  CAS  PubMed  Google Scholar 

Fujimoto, M. et al. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum. 64, 513–522 (2012).

Article  CAS  PubMed  Google Scholar 

Targoff, I. N. et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 54, 3682–3689 (2006).

Article  CAS  PubMed  Google Scholar 

Gunawardena, H. et al. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum. 60, 1807–1814 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Betteridge, Z., Gunawardena, H., North, J., Slinn, J. & McHugh, N. Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum. 56, 3132–3137 (2007).

Article  CAS  PubMed  Google Scholar 

Van Gompel, E. et al. Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains. Rheumatology 63, 1466–1473 (2024).

Article  PubMed  Google Scholar 

Pinal-Fernandez, I. et al. Pathological autoantibody internalisation in myositis. Ann. Rheum. Dis. 83, 1549–1560 (2024).

PubMed  Google Scholar 

Nombel, A., Fabien, N. & Coutant, F. Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front. Immunol. 12, 773352 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mamyrova, G. et al. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America. Rheumatology 60, 1839–1849 (2021).

Article  CAS  PubMed  Google Scholar 

Ueki, M. et al. Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies. Mod. Rheumatol. 29, 351–356 (2019).

Article  CAS  PubMed  Google Scholar 

Narang, N. S., Casciola-Rosen, L., Li, S., Chung, L. & Fiorentino, D. F. Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease. Arthritis Care Res. 67, 667–672 (2015).

Article  CAS  Google Scholar 

Lu, X., Peng, Q. & Wang, G. Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress. Nat. Rev. Rheumatol. 20, 48–62 (2024).

Article  CAS  PubMed  Google Scholar 

Yamasaki, Y. et al. Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study. Rheumatology 60, 4821–4831 (2021).

Article  CAS  PubMed  Google Scholar 

Liu, L. et al. Predictors of mortality for dermatomyositis patients positive with anti-melanoma differentiation-related gene 5 and optimal treatment. Clin. Exp. Rheumatol. 42, 246–252 (2024).

PubMed  Google Scholar 

Wang, H. et al. Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody. Arthritis Res. Ther. 25, 127 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhandari, S. et al. A review of MDA-5 dermatomyositis and associated interstitial lung disease. Rhe